- 2025-04-12 18:03Thalidomide-azetidine-piperazine-C2-OC-boc
- 2025-04-12 18:032'-Deoxy-N2-isopropyl guanosine 201528-73-6
- 2025-04-12 18:03SARS-CoV-2-IN-89 1016762-41-6
- 2025-04-12 18:038-Chloro-2'-O-methyl inosine
- 2025-04-12 18:03Talazoparib (BMN 673; MDV3800) 1207456-01-6
- 2025-04-12 18:03Mancozeb 8018-01-7
- 2025-04-12 18:03Cefadroxil-d4 hydrate (BL-S 578-d4 hydrate) 1426174-38-0
- 2025-04-12 18:03Caspase-3/7 activator 3
- 2025-04-12 18:03HL-Dbu(N3)-OH hydrochloride
- 2025-04-12 18:03hSMG-1 inhibitor 11e 1402452-10-1
- 2025-04-12 18:03Brr2 inhibitor C9 2104030-82-0
- 2025-04-12 18:03β-Carboline-1-propionic acid 89915-39-9
- 2025-04-12 18:03Thalidomide-azetidine-piperazine-C2-O-C2-OH
- 2025-04-12 18:03Violanone 52250-38-1
- 2025-04-12 18:038-Chloro-2'-deoxy-2'-fluoroadenosine
- 2025-04-12 18:032'-Deoxy-N2-cyclopentyl guanosine 1353757-90-0
- 2025-04-12 18:03SARS-CoV-2-IN-86 368866-07-3
- 2025-04-12 18:03Talazoparib racemic 1207456-00-5
- 2025-04-12 18:03Dihydrochelerythrine 6880-91-7
- 2025-04-12 18:03Halo-DBCO 1808119-16-5
